1. Home
  2. IBIO vs KXIN Comparison

IBIO vs KXIN Comparison

Compare IBIO & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBIO
  • KXIN
  • Stock Information
  • Founded
  • IBIO 2008
  • KXIN 2015
  • Country
  • IBIO United States
  • KXIN China
  • Employees
  • IBIO N/A
  • KXIN N/A
  • Industry
  • IBIO Biotechnology: Pharmaceutical Preparations
  • KXIN Retail-Auto Dealers and Gas Stations
  • Sector
  • IBIO Health Care
  • KXIN Consumer Discretionary
  • Exchange
  • IBIO Nasdaq
  • KXIN Nasdaq
  • Market Cap
  • IBIO 16.4M
  • KXIN 16.9M
  • IPO Year
  • IBIO N/A
  • KXIN N/A
  • Fundamental
  • Price
  • IBIO $1.54
  • KXIN $0.83
  • Analyst Decision
  • IBIO Strong Buy
  • KXIN
  • Analyst Count
  • IBIO 4
  • KXIN 0
  • Target Price
  • IBIO $4.50
  • KXIN N/A
  • AVG Volume (30 Days)
  • IBIO 7.2M
  • KXIN 784.9K
  • Earning Date
  • IBIO 10-31-2025
  • KXIN 11-26-2019
  • Dividend Yield
  • IBIO N/A
  • KXIN N/A
  • EPS Growth
  • IBIO N/A
  • KXIN N/A
  • EPS
  • IBIO N/A
  • KXIN N/A
  • Revenue
  • IBIO $400,000.00
  • KXIN $95,000.00
  • Revenue This Year
  • IBIO N/A
  • KXIN N/A
  • Revenue Next Year
  • IBIO N/A
  • KXIN N/A
  • P/E Ratio
  • IBIO N/A
  • KXIN N/A
  • Revenue Growth
  • IBIO 77.78
  • KXIN N/A
  • 52 Week Low
  • IBIO $0.56
  • KXIN $0.57
  • 52 Week High
  • IBIO $6.89
  • KXIN $7.30
  • Technical
  • Relative Strength Index (RSI)
  • IBIO 77.05
  • KXIN 55.01
  • Support Level
  • IBIO $1.02
  • KXIN $0.81
  • Resistance Level
  • IBIO $1.72
  • KXIN $0.94
  • Average True Range (ATR)
  • IBIO 0.19
  • KXIN 0.11
  • MACD
  • IBIO 0.06
  • KXIN 0.02
  • Stochastic Oscillator
  • IBIO 80.82
  • KXIN 54.36

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.

Share on Social Networks: